These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24173108)

  • 1. Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides.
    Valkenburg SA; Quiñones-Parra S; Gras S; Komadina N; McVernon J; Wang Z; Halim H; Iannello P; Cole C; Laurie K; Kelso A; Rossjohn J; Doherty PC; Turner SJ; Kedzierska K
    Nat Commun; 2013; 4():2663. PubMed ID: 24173108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.
    Cukalac T; Moffat JM; Venturi V; Davenport MP; Doherty PC; Turner SJ; Stambas J
    Vaccine; 2009 Nov; 27(48):6755-61. PubMed ID: 19744584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1
    van de Sandt CE; Pronk MR; van Baalen CA; Fouchier RAM; Rimmelzwaan GF
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice.
    Matsui M; Kohyama S; Suda T; Yokoyama S; Mori M; Kobayashi A; Taneichi M; Uchida T
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1494-9. PubMed ID: 20060099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of CD8+ T cells with highly focused specificity during viral persistence in the central nervous system.
    Marten NW; Stohlman SA; Smith-Begolka W; Miller SD; Dimacali E; Yao Q; Stohl S; Goverman J; Bergmann CC
    J Immunol; 1999 Apr; 162(7):3905-14. PubMed ID: 10201909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.
    van de Sandt CE; Kreijtz JH; de Mutsert G; Geelhoed-Mieras MM; Hillaire ML; Vogelzang-van Trierum SE; Osterhaus AD; Fouchier RA; Rimmelzwaan GF
    J Virol; 2014 Feb; 88(3):1684-93. PubMed ID: 24257602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
    Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
    J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P
    Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen.
    Milligan GN; Morrison LA; Gorka J; Braciale VL; Braciale TJ
    J Immunol; 1990 Nov; 145(10):3188-93. PubMed ID: 1700000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations.
    Turner SJ; Kedzierska K; Komodromou H; La Gruta NL; Dunstone MA; Webb AI; Webby R; Walden H; Xie W; McCluskey J; Purcell AW; Rossjohn J; Doherty PC
    Nat Immunol; 2005 Apr; 6(4):382-9. PubMed ID: 15735650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines.
    Lau YF; Deliyannis G; Zeng W; Mansell A; Jackson DC; Brown LE
    Int Immunol; 2006 Dec; 18(12):1801-13. PubMed ID: 17077175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
    Altenburg AF; Rimmelzwaan GF; de Vries RD
    Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
    Rimmelzwaan GF; Boon AC; Voeten JT; Berkhoff EG; Fouchier RA; Osterhaus AD
    Virus Res; 2004 Jul; 103(1-2):97-100. PubMed ID: 15163496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
    Rimmelzwaan GF; Kreijtz JH; Bodewes R; Fouchier RA; Osterhaus AD
    Vaccine; 2009 Oct; 27(45):6363-5. PubMed ID: 19840674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.
    Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K
    J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones.
    Berkhoff EGM; Geelhoed-Mieras MM; Fouchier RAM; Osterhaus ADME; Rimmelzwaan GF
    J Gen Virol; 2007 Feb; 88(Pt 2):530-535. PubMed ID: 17251571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.
    Price GE; Ou R; Jiang H; Huang L; Moskophidis D
    J Exp Med; 2000 Jun; 191(11):1853-67. PubMed ID: 10839802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.
    Valkenburg SA; Gras S; Guillonneau C; La Gruta NL; Thomas PG; Purcell AW; Rossjohn J; Doherty PC; Turner SJ; Kedzierska K
    PLoS Pathog; 2010 Aug; 6(8):e1001039. PubMed ID: 20711359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection.
    Guglietta S; Garbuglia AR; Salichos L; Ruggeri L; Folgori A; Perrone MP; Camperio C; Mellace V; Maio G; Maio P; Capobianchi MR; Spada E; Gargano N; Scottà C; Piccolella E; Del Porto P
    Virology; 2009 Apr; 386(2):398-406. PubMed ID: 19232664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redundancy of the influenza A virus-specific cytotoxic T lymphocyte response in HLA-B*2705 transgenic mice limits the impact of a mutation in the immunodominant NP(383-391) epitope on influenza pathogenesis.
    Bodewes R; Geelhoed-Mieras MM; Nieuwkoop NJ; Hanson JA; David CS; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Virus Res; 2011 Jan; 155(1):123-30. PubMed ID: 20863862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.